KV Pharmaceutical
     
9/6/2010 9:25:52 PM   KV.A:   KV.B:  
 
Recent Headlines
 
     
Financial Highlights
News
Recent Headlines
Press Releases
Conference Calls
Media Contacts
Investor Events
Investor FAQs
Investor Contacts
Annual Report & Proxy Statements
Corporate Governance
SEC Filings
Recent Headlines
  
K-V Pharmaceutical Company Receives Notification From New York Stock Exchange Of Compliance With Quantitative Continued Listing Standards
September 02, 2010 - September 2, 2010, St. Louis, MO. - K-V Pharmaceutical Company (NYSE: KVa/KVb) announced today that it has received notification from the New York Stock Exchange (“NYSE”) stating that the Company has reestablished compliance with the NYSE’s minimum share price requirements for continued listing on an accelerated basis.
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
August 09, 2010 - August 9, 2010, 5t. Louis, MO. - K-V Pharmaceutical Company (NYSE: KVa/KVb) announced today that Mr. Robert Baldini was appointed as a new independent member of the Board of Directors by a unanimous vote of the directors, which also voted to increase the size of the Board to eight directors.
K-V Pharmaceutical Company Engages BDO USA, LLP as Independent Registered Accountants
August 03, 2010 - August 3, 2010, St. Louis, MO. – K-V Pharmaceutical Company (NYSE: KVa.KVb) announced today that the Audit Committee of its Board of Directors has engaged BDO USA, LLP (“BDO”) as the Company’s independent registered accounting firm.
 
Home | Contact Us | Site Directory | Legal/Privacy | Compliance Program ©2010 KV Pharmaceutical Company. All Rights Reserved.